Abiopharma

Alcon - Alcon Completes $750 Million Share Repurchase Program

METTLER TOLEDO Announces Michael J. Tokich to Join Board of Directors

Royalty Pharma to Announce Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026

DuPont Announces Appointment of D.G. Macpherson to Board of Directors

UTHR: Notification

Halozyme - Halozyme to Host Investor Conference Call to Provide Updated Financial Guidance and Business Update

Aytu BioPharma Recaps Investor Day Held on January 20, 2026

Halozyme to Host Investor Conference Call to Provide Updated Financial Guidance and Business Update

Charles River Laboratories Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL

Fortrea Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fortrea Holdings, Inc. - FTRE